Warhound Spends $200M to Engineer New Military Dogs
A new venture backed by tech founders aims to clone genetically enhanced dogs for U.S. defense and emergency teams.
By Aiko Petrov ·

For the first time, U.S. military and law enforcement units may receive dogs that are genetically engineered for specific jobs. This shift addresses a growing shortage of working dogs in the country. The goal is to create animals that are healthier and better suited for dangerous tasks than current breeds.
Warhound officially emerged from stealth mode on Thursday. The company secured $200 million in funding. Investors include Sequoia, 8VC, Corner Ventures, and In-Q-Tel. This venture firm has ties to the CIA and other U.S. intelligence agencies. The round values Warhound at $1.2 billion.
The company was founded by Ben Lamm of Colossal Biosciences and Palmer Luckey of Anduril. They met a year ago and discussed the state of military working dogs. Lamm noted that over 80% of U.S. military dogs come from Europe. Less than half of those imported dogs are fit for service. This creates a heavy reliance on foreign supply chains for a critical military asset.
Warhound plans to edit the genes of top-performing breeds like the Belgian Malinois and German Shepherd. The process involves removing genes linked to health issues such as cancer, hip dysplasia, and poor eyesight. It also adds genes to improve speed, agility, and smell. The first batch of clones is expected to be born early next year. Service could begin within two years.
Anduril will provide the hardware and software for these animals. Their gear includes protection vests and goggles with data sensors. This technology helps handlers monitor the dog's condition and surroundings in real time. Lamm described the approach as enhancing the dog on the outside, rather than just inside. He believes this will protect both the animal and its human handler.
Colossal Biosciences is known for its de-extinction work, such as efforts to bring back the mammoth. It licenses its technology to Warhound. Another Colossal-owned company, Viagen, will handle the cloning process. Lamm stated that Viagen has a high success rate in cloning. This expertise is already used in programs for endangered species.
The company is working with the American Humane Society to certify its training programs. The group aims to ensure the dogs are treated humanely. They also hope to place retired dogs into the Society's reunification programs. Lamm said the company has briefed various government groups. He noted that each dog will be trained like any standard military working dog. The company has not yet set a price for the animals.
Source: TechCrunch · original report published





